An ab initio study of At2 antagonists

Chemical Biology and Drug Design

Volumn 71, Issue 3, 2008, Pages 271-277

  Jain, Swati ^a   Yadav, Arpita ^a  

^a CSJM UNIVERSITY   (India)

Author keywords

Angiotensin II; AT2 antagonist; Competitive inhibition; Pharmacophore

Indexed keywords

1 (4 AMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDROIMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; 1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1 (4 METHOXY 3 METHYLBENZYL) 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; ANGIOTENSIN II ANTAGONIST; EXP 801; L 159686; LIGAND; PD 126055; UNCLASSIFIED DRUG;

AB INITIO CALCULATION; ARTICLE; DRUG MECHANISM; DRUG POTENCY; DRUG STRUCTURE; HYPERTENSION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BLOCKING; VASOCONSTRICTION;

ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; BINDING SITES; ELECTROSTATICS; MODELS, MOLECULAR;

EID: 38849103119     PISSN: 17470277     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1747-0285.2008.00634.x     Document Type: Article

References (41)

1. Ondetti M.A., Rubin A., Cushman D.W. (1977) Design of specific inhibitors of angiotensin converting enzyme: New class of orally active antihypertensive agents. Science 196 : 441 444.
2. Ondetti M.A., Cushman D.W. (1981) Inhibitors of the renin-angiotensin system: A new approach to the therapy of hypertension. J Med Chem 24 : 355 361.
3. Ondetti M.A., Cushman D.W. (1982) Enzymes of the renin-angiotensin system and their inhibitors. Ann Rev Biochem 51 : 283 308.
4. Patchett A., Harris E., Tistram E., Wyvratt M.J., Wu M.T., Taub D., Peterson E.R. et al. (1980) A new class of angiotensin converting enzyme inhibitors. Nature 288 : 280 283.
5. Vallotten M.B. (1987) The renin angiotensin system. Trends Pharmacol Sci 8 : 69 74.
6. Areavey D.Mc., Robertson J.I.S. (1990) Angiotensin converting enzyme inhibitors and moderate hypertension. Drugs 40 : 326 345.
7. Waeber B., Nussberger J., Brunner H.R. (1990) Hypertension. In : Laragh J.H., Brenner B.H., editors. Pathophysiology, Diagnosis and Management. New York : Raven Press p. 2209 2232.
8. Chiu A.T., Herblin W.F., Mc Call D.E., Ardecky R.J., Carini D.J., Duncia J.V., Pease L.J., Wong P.C., Wexler R.R., Johnson A.L. (1989) Identification of angiotensin II receptor subtypes Biochem. Biophys Res Commun 165 : 196 203.
9. Mukoyama M., Nakajima M., Horiuchi M., Sasamura H., Pratt R.E., Dzau V.J. (1993) Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven-transmembrane receptors. J Biol Chem 268 : 24539 24542.
10. Kambayashi Y., Bardhan S., Takahashi K., Tsuzuki S., Inui H., Hamakubo T., Inagami T. (1993) Molecular cloning of a novel angiotensin II receptor isoform involved in phosphotyrosine phosphatase inhibition. J Biol Chem 268 : 24543 24546.
11. Deraet M., Rihakova L., Boucard A., Perodin J., Sauve S., Mathieu A.P., Guillemette G., Leduc R., Lavigne P., Escher E. (2002) Angiotensin II is bound to both receptors AT1 and AT2, parallel to the transmembrane domains and in extended form. Can J Physiol Pharmacol 80 : 418 425.
12. Lindman S., Lindeberg G., Frandeberg P.A., Nyberg F., Karlen A., Hallberg A. (2003) Effect of 3-5 monocyclizations of angiotensin II and 4-amino Phe6-Ang II on AT2 receptor affinity. Bioorg Med Chem 11 : 2947 2954.
13. 2 receptor ligand with a gamma-turn like mimetic replacing the amino acid residues 4-5 of angiotensin II. J Med Chem 47 : 859 870.
14. Horiuchi M. (1996) Functional aspects of angiotensin type 2 receptor. Adv Exp Med Biol 396 : 217 224.
15. Csikos T., Chung O., Unger T. (1998) Receptors and their classification: Focus on angiotensin II and the AT2 receptor. J Hum Hypertens 12 : 311 318.
16. 2 receptors in NG108-15 cells. Effect counteracted by the AT1 receptors. J Biol Chem 271 : 22729 22735.
17. Gendron L., Oligny J.F., Payet M.D., Gallo-Payet N. (2003) Cyclic AMP-independent involvement of Rap1/B-Raf in the Angiotensin II AT2 receptor signaling pathway in NG108-15 cells. J Biol Chem 278 : 3606 3614.
18. Yadav A., Singh S.K. (2004) Threshold interaction energy of NRTI's (2'-deoxy 3'-substituted nucleosidic analogs of reverse transcriptase inhibitors) to undergo competitive inhibition Bioorg. Med Chem Lett 14 : 2677 2680.
19. Ditchfield R., Hehre W.J., Pople J.A. (1971) Self consistent molecular orbital methods, IX: An extended Gaussian-type basis for molecular orbital studies of organic molecules. J Chem Phys 54 : 724 728.
20. Hehre W.J., Ditchfield R., Pople J.A. (1972) Self consistent molecular orbital methods XII: Further extensions of Gaussian type basis sets for use in molecular orbital studies of organic molecules. J Chem Phys 56 : 2257 2261.
21. n equilibrium geometries by single determinant molecular orbital theory. Mol Phys 27 : 209 214.
22. Gordon M.S. (1980) The isomers of silacyclopropane. Chem Phys Lett 76 : 163 168.
23. Hariharan P.C., Pople J.A. (1973) The influence of polarization functions on molecular orbital hydrogenation energies. Theo Chim Acta 28 : 213 222.
24. Frisch M.J., Pople J.A., Binkley J.S. (1984) Self-consistent molecular orbital methods, 25 supplementary functions for Gaussian basis sets. J Chem Phys 80 : 3265 3269.
25. Binkley J.S., Pople J.A., Hehre W.J. (1980) Self consistent molecular orbital method 21: Small split valence basis sets for first row elements. J Am Chem Soc 102 : 939 947.
26. Gordon M.S., Binkley J.S., Pople J.A., Pietro W.J., Hehre W.J. (1982) Self consistent molecular orbital methods 22: Small split valence basis sets for second row elements. J Am Chem Soc 104 : 2797 2803.
27. Pietro W.J., Francl M.M., Hehre W.J., Defrees D.J., Pople J.A., Binkley J.S. (1982) Self consistent molecular orbital methods 24: Supplemented small split valence basis sets for second row elements. J Am Chem Soc 104 : 5039 5048.
28. Peng C., Ayala P.Y., Schlegel H.B., Frisch M.J. (1996) Using redundant internal coordinates to optimize equilibrium geometries and transition states. J Comp Chem 17 : 49 56.
29. Peng C., Schlegel H.B. (1994) Combining synchronous transit and quasi-newton methods for finding transition states. Isr J Chem 33 : 449.
30. Frisch M.J., Trucks G.W., Schlegel H.B., Scuseria G.E., Robb M.A., Cheeseman J.R., Montgomery J.A. Jr. et al. (2004) Gaussian 03, Revision C.02. Wallingford, CT : Gaussian, Inc.
31. Breneman C.M., Wiberg K.B. (1990) Determining atom centered monopoles from molecular electrostatic potentials. The need for high sampling density in formamide conformational analysis. J Comp Chem 11 : 361 373.
32. Peitsch M.C. (1995) Protein modeling by email. Nat Biotechnol 13 : 658 660.
33. Peitsch M.C. (1996) PROMOD and SWISS-MODEL: Internet based tools for automated comparative protein modeling. Biochem Soc Trans 24 : 274.
34. Peitsch M.C., Guex N. (1997) Large-scale comparative protein modeling. In : Wilkins M.R., editor. Proteome Research: New Frontiers in Functional Genomics. Springer-Verlag, New York, USA : p. 177.
35. Peitsch M.C., Guex N. (1997) Swiss-model and the Swiss-PDB viewer: An environment for comparative protein modeling. Electrophoresis 18 : 2714 2723.
36. Schwede T., Kopp J., Guex N., Peitsch M.C. (2003) Swiss-model: An automated protein homology modeling server. Nucleic Acids Res 31 : 3381 3385.
37. Pulakat L., Tadessee A.S., Dittus J.J., Gavini N. (1998) Role of Lys 215 located in the fifth transmembrane domain of the AT2 receptor in ligand-receptor interaction. Regul Pept 73 : 51 57.
38. Turner C.A., Cooper S., Pulakat L. (1999) Role of His 273 located in the sixth transmembrane domain of the angiotensin II receptor subtype AT2 in ligand-receptor interaction. Biochem Biophys Res Commun 257 : 704 707.
39. Dittus J., Cooper S., Obermair G., Pulakat L. (1999) Role of the third intracellular loop of the Angiotensin II receptor subtype AT2 in ligand-receptor interaction. FEBS Lett 445 : 23 26.
40. Jain S., Yadav A. (2007) Ab initio study of non-peptidic antihypertensives. Chem Biol Drug Des 69 : 251 257.
41. Wexler R.R., Greenlee W.J., Irvin J.D., Goldberg M.R., Prendergast K., Smith R.D., Timmermans P.B.M.W.M. (1996) Nonpeptide Angiotensin II receptor antagonists: The next generation in antihypertensive therapy. J Med Chem 39 : 625 656.